Home › Stocks › BCRX › All Fund Holders
BCRX — BIOCRYST PHARMACEUTICALS INC · All Fund Holders
Funds holding (latest): 46 · Reported value held: $1.06B
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 23.89M | $238.93M | 0.00% | Add |
| Vanguard Group history | Q4 2025 | 22.27M | $173.73M | 0.00% | Add |
| Janus Henderson Group history | Q1 2026 | 8.91M | $84.85M | 0.04% | Add |
| Two Sigma Investments history | Q2 2026 | 6.78M | $67.75M | 0.05% | Add |
| Geode Capital Management history | Q2 2026 | 6.25M | $62.49M | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 5.08M | $50.78M | 0.02% | Add |
| Bank of America Corp history | Q2 2026 | 4.80M | $48.01M | 0.00% | Reduce |
| Goldman Sachs Group history | Q2 2026 | 4.48M | $44.82M | 0.01% | Add |
| Alkeon Capital Management history | Q3 2025 | 5.46M | $41.47M | 0.06% | Reduce |
| Millennium Management history | Q2 2026 | 3.39M | $33.95M | 0.01% | Add |
| Renaissance Technologies history | Q2 2026 | 2.53M | $25.30M | 0.04% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 2.35M | $23.53M | 0.00% | Hold |
| Northern Trust Corp history | Q2 2026 | 2.26M | $22.56M | 0.00% | Add |
| AQR Capital Management history | Q2 2026 | 2.21M | $22.14M | 0.01% | Add |
| Morgan Stanley history | Q2 2026 | 2.00M | $20.00M | 0.00% | Reduce |
| Legal & General Investment Management America history | Q2 2026 | 1.46M | $14.56M | 0.00% | Add |
| Invesco Ltd history | Q2 2026 | 1.23M | $12.34M | 0.00% | Reduce |
| Moore Capital Management history | Q2 2026 | 848.34K | $8.48M | 0.13% | New |
| Fidelity Management & Research (FMR) history | Q2 2026 | 808.90K | $8.09M | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 680.48K | $6.80M | 0.00% | Add |
| Deutsche Bank AG history | Q2 2026 | 563.36K | $5.63M | 0.00% | Reduce |
| Citigroup Inc history | Q2 2026 | 550.19K | $5.50M | 0.00% | Add |
| Bridgewater Associates history | Q2 2026 | 491.06K | $4.91M | 0.02% | Reduce |
| Franklin Resources history | Q2 2026 | 480.36K | $4.80M | 0.00% | Reduce |
| Principal Global Investors history | Q2 2026 | 468.79K | $4.69M | 0.00% | Add |
| D. E. Shaw & Co history | Q2 2026 | 408.53K | $4.09M | 0.00% | Add |
| Wellington Management Group history | Q2 2026 | 293.93K | $2.94M | 0.00% | Add |
| Point72 Asset Management history | Q2 2026 | 260.92K | $2.61M | 0.01% | New |
| Marshall Wace history | Q2 2026 | 252.76K | $2.53M | 0.00% | Add |
| Wells Fargo & Co history | Q2 2026 | 222.89K | $2.23M | 0.00% | Reduce |
| PSP Investments history | Q3 2025 | 264.80K | $2.01M | 0.01% | New |
| Balyasny Asset Management history | Q1 2026 | 186.12K | $1.77M | 0.00% | New |
| Citadel Advisors history | Q2 2026 | 145.00K | $1.45M | 0.00% | Reduce |
| Manulife Financial history | Q2 2026 | 119.52K | $1.20M | 0.00% | Add |
| CPP Investments history | Q2 2026 | 115.81K | $1.16M | 0.00% | Reduce |
| MFS Investment Management history | Q3 2025 | 131.71K | $999.69K | 0.00% | Add |
| Norges Bank Investment Management history | Q2 2025 | 111.15K | $995.92K | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q2 2026 | 57.40K | $548.17K | 0.00% | New |
| Arrowstreet Capital history | Q4 2025 | 66.24K | $516.70K | 0.00% | Reduce |
| Prudential Financial history | Q2 2026 | 39.13K | $391.26K | 0.00% | Reduce |
| Farallon Capital Management history | Q1 2026 | 24.00K | $228.48K | 0.00% | Hold |
| PNC Financial Services history | Q2 2026 | 21.83K | $218.32K | 0.00% | Add |
| Lazard Asset Management history | Q2 2026 | 21.00K | $210.00K | 0.00% | Reduce |
| Amundi US history | Q2 2026 | 16.94K | $169.44K | 0.00% | New |
| Baillie Gifford & Co history | Q1 2023 | 1.69K | $14.07K | 0.00% | Hold |
| T. Rowe Price Associates history | Q2 2026 | 305.90K | $3.06K | 0.00% | Add |